| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |